Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Rolls-Royce Holdings | 7.81% | $65.63M | £105.77B | 142.15% | 71 Outperform | |
| Babcock International | 5.71% | $48.02M | £7.18B | 191.16% | 67 Neutral | |
| Prosus | 3.44% | $28.94M | €118.69B | 71.95% | 77 Outperform | |
| Teva Pharmaceutical | 3.28% | $27.55M | $37.27B | 55.25% | 63 Neutral | |
| Siemens Energy | 2.75% | $23.12M | $128.43B | 180.73% | 72 Outperform | |
| Societe Generale | 2.72% | $22.86M | €45.80B | 158.10% | 72 Outperform | |
| Companhia De Saneamento | 2.62% | $21.99M | $16.94B | 76.31% | 71 Outperform | |
| Brookfield Corporation | 2.57% | $21.61M | $116.61B | 29.05% | 65 Neutral | |
| Nebius Group | 2.48% | $20.88M | $24.23B | 193.25% | 46 Neutral | |
| Novo Nordisk | 2.43% | $20.45M | $253.58B | -33.53% | 73 Outperform |